PM 2.5 promotes pulmonary fibrosis by mitochondrial dysfunction
Environmental Toxicology · 2023-08 · 38 (8) · 1905-1913
DOI: 10.1002/tox.23817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2023-05. Verfasst von En-Ming Chang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Care, Shin Kong Wu Ho Su Memorial Hospital, Taipei City, Taiwan. Hauptthemen laut MEDLINE: Pulmonary Fibrosis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Pulmonary fibrosis is known as an incurable lung disorder with irreversible progression of chronic injury, myofibroblast proliferation, extracellular matrix (ECM) accumulation, and tissue scarring. Atmospheric particulate matter 2.5 (PM 2.5 ) is implicated as a risk factor of several diseases, especially lung diseases such as pulmonary fibrosis. The molecular mechanism which participates PM 2.5 ‐induced pulmonary fibrosis in type II alveolar cells (AEII) has yet to be determined. Our results proved that short‐ and long‐term exposure to PM 2.5 significantly stimulated epithelial‐mesenchymal transition (EMT) activity in AEII cells, according to, changes in gene signature analyzed by RNA‐seq and cell morphology. Furthermore, Gene Ontology (GO) enrichment analysis also suggested that mitochondrial dysfunction was related to progression of pulmonary fibrosis in AEII after PM 2.5 exposure. We observed a marked decline in mitochondria membrane potential (MMP), as well as fragmented mitochondria, in AEII cells exposed to PM 2.5 , which suggests that energy metabolism is suppressed after PM 2.5 exposure. We also confirmed that PM 2.5 exposure could influence the expression levels of Mfn1, Mfn2, and Drp1 in AEII. Pretreatment of mitochondrial fusion promoter M1 was able to reverse mitochondrial dysfunction as well as EMT in AEII. These data suggested the key role of mitochondrial fragmentation in AEII, which was induced by PM 2.5 exposure, and participated pathogenesis of pulmonary fibrosis. Finally, we investigated the response of lung tissue exposed to PM 2.5 in vivo. The data indicated that the lung tissue exposed to PM 2.5 obviously induced collagen accumulation. Moreover, IHC results revealed that PM 2.5 enhanced Drp1 expression but suppressed Mfn1 and Mfn2 expression in lung tissue. The current study provides novel insight of pulmonary fibrosis caused by PM 2.5 exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Care, Shin Kong Wu Ho Su Memorial Hospital, Taipei City, Taiwan.
- Department of Respiratory Therapy, Fu Jen Catholic University, New Taipei City, Taiwan.
- Division of Physical Medicine and Rehabilitation, Fu Jen Catholic University Hospital, Taipei, Taiwan.
- Department of Medical Research, National Taiwan University Hospital, Taipei City, Taiwan.
- School of Life Science, National Taiwan Normal University, Taipei City, Taiwan.
- Translational Medicine Center, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei City, Taiwan.
Zitieren
APA
Chang, E. M., Chao, C. C., Wang, M. T., Hsu, C. L., & Chen, P. C. (2023). PM 2.5 promotes pulmonary fibrosis by mitochondrial dysfunction. Environmental Toxicology, 38(8), 1905-1913. https://doi.org/10.1002/tox.23817
Vancouver
Chang EM, Chao CC, Wang MT, Hsu CL, Chen PC. PM 2.5 promotes pulmonary fibrosis by mitochondrial dysfunction. Environmental Toxicology. 2023;38(8):1905-1913. doi:10.1002/tox.23817
BibTeX
@article{Chang2023,
author = {Chang, En-Ming and Chao, Chia-Chia and Wang, Mei-Ting and Hsu, Chia-Lang and Chen, Po-Chun},
title = {PM 2.5 promotes pulmonary fibrosis by mitochondrial dysfunction},
journal = {Environmental Toxicology},
year = {2023},
volume = {38},
number = {8},
pages = {1905--1913},
doi = {10.1002/tox.23817}
}
EUVIMED